Clinical and experimental experiences with intravenous vitamin C

Journal of Orthomolecular Medicine

Volumn 15, Issue 4, 2000, Pages 201-213

  Riordan, Neil H ^a   Riordan, Hugh D ^a   Casciari, Joseph P ^a  

^a Bio Communications Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVASE R; ALTEPLASE; ASCORBIC ACID; COLLAGEN; DEXAMETHASONE; DOXORUBICIN; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; NARCOTIC AGENT; THIOCTIC ACID; UBIDECARENONE;

CANCER; CANCER CHEMOTHERAPY; COLLAGEN SYNTHESIS; COMPARTMENT MODEL; COMPUTER SIMULATION; CONFERENCE PAPER; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG MECHANISM; DRUG MEGADOSE; DRUG POTENTIATION; HUMAN; IN VITRO STUDY; TREATMENT OUTCOME;

EID: 0034500498     PISSN: 03170209     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (6)

1. Benade L, Howard T, Burk D: Synergistic killing of Ehrlich ascites carcinoma cells by ascorbate and 3-amino-1, 2, 4-triazole. Oncology, 1969; 23: 33-43.
2. Maramag C, Menon M, Balaji KC, Reddy PG, Laxmanan S: Effect of vitamin C on prostate cancer cells in vitro: effect on cell number, viability, and DNA synthesis. Prostate, 1997; 32: 188-95.
3. Riordan NH, et al: Intravenous ascorbate as a tumor cytotoxic chemotherapeutic agent. Med Hypoth, 1994; 9: 207-213.
4. Riordan HD, Jackson JA, Schultz M: Case study: High-dose intravenous vitamin C in the treatment of a patient with adenocarcinoma of the kidney. J Orthomol Med, 1990; 5: 5-7.
5. Riordan HD, Jackson JA, Riordan NH, Schultz M: High-dose intravenous vitamin C in the treatment of a patient with renal cell carcinoma of the kidney. J Orthomol Med, 1998; 13: 72-73.
6. Riordan N, Jackson JA, Riordan HD: Intravenous vitamin C in a terminal cancer patient. J Orthomol Med, 1996; 11: 80-82.